VCA
COLL icon

Verdence Capital Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Verdence Capital Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829K Sell
22,892
-1,259
-5% -$43K 0.04% 339
2026
Q1 		$799K Buy
+24,151
New +$1.02M 0.05% 337

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Verdence Capital Advisors's COLL Position: Q2 2026 in Review

Verdence Capital Advisors reduced its Collegium Pharmaceutical (COLL) stake by 5.2% in Q2 2026, selling an estimated $43K and leaving 22,892 shares worth $829K. The position accounts for 0.04% of the portfolio, ranked #339.

Verdence Capital Advisors first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Verdence Capital Advisors held 22,892 shares of Collegium Pharmaceutical worth $829K as of Q2 2026.
  • Verdence Capital Advisors sold 1,259 Collegium Pharmaceutical shares in Q2 2026, an estimated $43K.
  • Collegium Pharmaceutical made up 0.04% of Verdence Capital Advisors's portfolio in Q2 2026, its #339 holding.
  • Verdence Capital Advisors first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.